CDER Division of Drug Labeling Compliance
This article was originally published in The Tan Sheet
Director Richard Chastonay is retiring after more than 30 years with FDA. Chastonay has been director since September 1989
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC